Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis

BACKGROUND: In this systematic review, we aimed to investigate the efficacy and safety of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin (LDA) started ≤16 weeks'gestation in the prevention of preeclampsia (PE) in high-risk women. METHODS: PubMed, Cochra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Li, Xia, Binbin, Yuan, Yuan, Wang, Yuran, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780488/
https://www.ncbi.nlm.nih.gov/pubmed/36568564
http://dx.doi.org/10.3389/fcvm.2022.1073148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780488/
https://www.ncbi.nlm.nih.gov/pubmed/36568564
http://dx.doi.org/10.3389/fcvm.2022.1073148

Ejemplares similares